Koyfin Home > Directory > Health Care > Aimmune Therap > Return on Capital %

Aimmune Therap Return on Capital % Chart (AIMT)

Aimmune Therap annual/quarterly Return on Capital % from 2015 to 2020.
  • Aimmune Therap Return on Capital % for the quarter ending June 06, 2020 was -47.23 a -47.92% increase of 22.63 year over year
  • Aimmune Therap Return on Capital % for the last 12 months ending June 06, 2020 was -61.00 a -9.15% increase of 5.58 year over year
  • Aimmune Therap Annual Return on Capital % for 2019 was -68.34 a 17.40% decrease of -11.89 from 2018
  • Aimmune Therap Annual Return on Capital % for 2018 was -56.45 a 36.37% decrease of -20.53 from 2017
  • Aimmune Therap Annual Return on Capital % for 2017 was -35.92 a 42.36% decrease of -15.22 from 2016
Other Margins & Efficiency Metrics:
  • Aimmune Therap Return on Equity % for the quarter ending September 09, 2018 was -77.31 a -9.68% increase of 7.48 year over year
View Chart On Koyfin

Quarterly AIMT Return on Capital % Data

06/2020-47.23
03/2020-79.94
12/2019-92.09
09/2019-69.86
06/2019-56.04
03/2019-45.38
12/2018-53.49
09/2018-49.51
06/2018-43.61
03/2018-49.44

Annual AIMT Return on Capital % Data

2019-68.34
2018-56.45
2017-35.92
2016-20.70
2015-21.75
2014-113.06